PROLIFERATIONSINHIBITOR

European patent · EP4049722 · In force

Register entry

Publication number
EP4049722
Application number
EP20880103
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 20, 2020
Published
Aug 31, 2022
Granted
Jul 15, 2026
Protection ends at the latest
Oct 19, 2040
Next annual fee due
Oct 31, 2027
IPC classes
A61P 3/10 (2006.01)
C12N 5/071 (2010.01)
C12N 5/0735 (2010.01)
C12N 5/10 (2006.01)
C12N 9/99 (2006.01)
A61K 35/545 (2015.01)
A61L 27/38 (2006.01)
Priority
JP 2019191876 21.10.2019
PCT application
PCT/JP2020/039380 20.10.2020
PCT publication
WO2021/079874 29.04.2021
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Aug 6, 2026

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 06.08.2026

  3. Jul 15, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.07.2026

Parties

Holder

Orizuru Therapeutics, Inc.

26-1, Muraoka-Higashi 2-chome, Fujisawa-shi Kanagawa 251-8555, JP

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

SAKUMA Kensuke

Fujisawa-shi, Kanagawa 251-0012, JP

YAMAZOE Noriko

Fujisawa-shi, Kanagawa 251-0012, JP

TOYODA Taro

Kyoto-shi, Kyoto 606-8501, JP

KONAGAYA Shuhei

Kyoto-shi, Kyoto 606-8501, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.